Shopping Cart
- Remove All
- Your shopping cart is currently empty
OICR-0547 is an inactive derivative of OICR-9429 and is commonly used as a negative control for OICR-9429. OICR-9429 is an inhibitor of the interaction between WDR5 and the mixed leukaemia (MLL) protein.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $60 | In Stock |
Description | OICR-0547 is an inactive derivative of OICR-9429 and is commonly used as a negative control for OICR-9429. OICR-9429 is an inhibitor of the interaction between WDR5 and the mixed leukaemia (MLL) protein. |
In vitro | OICR-0547 (0.1-100 μM) was used to treat K562 cells and Cebpap30/p30 cells. OICR-0547 had no effect on the viability of either cell line. [1] |
In vivo | OICR-0547 (3 mg/kg, intravenous injection) and (30 mg/kg, intraperitoneal injection) can be used as a negative control model in NOD-SCID mice.[2] |
Synonyms | OICR0547 |
Molecular Weight | 542.55 |
Formula | C28H29F3N4O4 |
Cas No. | 1801873-49-3 |
Smiles | O=C1C=C(C(=CN1)C(=O)NC2=CC(=CC=C2N3CCOCC3)C=4C=CC=C(C4)CN5CCOCC5)C(F)(F)F |
Relative Density. | 1.358 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 180 mg/mL (331.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.